SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 104 000 KRW -0.1% Market Closed
Market Cap: 8.1T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

Net Margin
SK Biopharmaceuticals Co Ltd

7.3%
Current
-20%
Average
4.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
7.3%
=
Net Income
33.8B
/
Revenue
465.1B

Net Margin Across Competitors

Country KR
Market Cap 8.1T KRW
Net Margin
7%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 756.5B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 364.1B USD
Net Margin
17%
Country US
Market Cap 248.4B USD
Net Margin
19%
Country CH
Market Cap 208.5B CHF
Net Margin
20%
Country CH
Market Cap 181.2B CHF
Net Margin
33%
Country UK
Market Cap 159.6B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%

Profitability Report

View the profitability report to see the full profitability analysis for SK Biopharmaceuticals Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
7.3%
=
Net Income
33.8B
/
Revenue
465.1B
What is the Net Margin of SK Biopharmaceuticals Co Ltd?

Based on SK Biopharmaceuticals Co Ltd's most recent financial statements, the company has Net Margin of 7.3%.